作者: A. Sood , D. McClain , R. Seetharam , M. Al-rahamneh , A. Kaubisch
DOI: 10.1200/JCO.2010.28.15_SUPPL.3567
关键词:
摘要: 3567 Background: EGFR directed therapy is limited by mutations in KRAS or BRAF; however, the search for other predictive biomarkers critical (Clin Cancer Res, 2008; 68: 1953). In our study, we e...